How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- 16 April 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 24 (3) , 164-170
Abstract
The prevalence of Diabetes Mellitus (DM) is becoming a serious public health problem. The use of atypical antipsychotics has been associated with disruption of the glucose metabolism and therefore with causing DM. The underlying mechanisms are unknown, but knowledge of the differences between the pharmacological features of various antipsychotics combined with their diabetogenic profile might help us to understand those mechanisms. This article describes how the binding of various essential receptors or transporters in essential body tissues, adipose tissue, pancreatic tissue and liver and skeletal muscle tissue can cause disruption of the glucose metabolism. With such knowledge in mind one can try to explain the differences between the diabetogenic propensities of various antipsychotics. It is well known that clozapine and olanzapine cause weight gain and DM, whereas aripiprazole and ziprasidone have much less disruptive clinical profiles. The most significant risk factor for adiposity seems to be strong blocking of histaminergic receptors. An agonistic activity on serotonergic-1a receptors, with a very low affinity for muscarinergic-3 receptors, might protect against the development of DM. More data will become available which may help to solve the puzzle.Keywords
This publication has 61 references indexed in Scilit:
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory SchizophreniaThe Journal of Clinical Psychiatry, 2008
- Critical Role of M3 Muscarinic Receptor in Insulin SecretionJournal of Clinical Psychopharmacology, 2006
- Unusual suspect for antipsychotic-induced diabetesDrug Discovery Today, 2005
- ErratumJournal of Clinical Psychopharmacology, 2005
- A Prospective Study of Impairment in Glucose Control Caused by Clozapine Without Changes in Insulin ResistanceAmerican Journal of Psychiatry, 2004
- Olanzapine Induces Insulin ResistanceThe Journal of Clinical Psychiatry, 2003
- Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With SchizophreniaAmerican Journal of Psychiatry, 2003
- Obseity, non-insulin-dependent diabetes mellitus and the metabolic syndromeBritish Medical Bulletin, 1997
- Body Fat and the Activity of the Autonomic Nervous SystemNew England Journal of Medicine, 1988
- Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the ratPharmacology Biochemistry and Behavior, 1984